Concentra Group Holdings Parent (CON) Stock Price, News & Analysis

Company Overview

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

Key Stats

• Today's Range: $20.74 to $21.34
• 50-Day Range: $19.29 to $23.59
• 52-Week Range: $18.89 to $24.81
• Volume: 110,293 shs
• Average Volume: 738,200 shs
• Market Capitalization: $2.63 billion
• P/E Ratio: 13.67
• Dividend Yield: 1.21%
• Price Target: $28.63
• Consensus Rating: Buy

CON Stock Analysis - Frequently Asked Questions

How have CON shares performed this year?

Concentra Group Holdings Parent's stock was trading at $19.78 at the beginning of 2025. Since then, CON stock has increased by 5.5% and is now trading at $20.8750.
View the best growth stocks for 2025 here.

How were Concentra Group Holdings Parent's earnings last quarter?

Concentra Group Holdings Parent, Inc. (NYSE:CON) issued its quarterly earnings data on Monday, March, 3rd. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $465 million for the quarter, compared to the consensus estimate of $465 million.

When did Concentra Group Holdings Parent IPO?

Concentra Group Holdings Parent (CON) raised $529 million in an initial public offering (IPO) on Thursday, July 25th 2024. The company issued 22,500,000 shares at $23.50 per share.

When did the company's lock-up period expire?

Concentra Group Holdings Parent's lock-up period expired on Tuesday, January 21st. Concentra Group Holdings Parent had issued 22,500,000 shares in its IPO on July 25th. The total size of the offering was $528,750,000 based on an initial share price of $23.50. Since the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Who are Concentra Group Holdings Parent's major shareholders?

Top institutional investors of Concentra Group Holdings Parent include Price T Rowe Associates Inc. MD (13.62%), Vanguard Group Inc. (9.68%), T. Rowe Price Investment Management Inc. (6.76%) and Dimensional Fund Advisors LP (2.61%).

How do I buy shares of Concentra Group Holdings Parent?

Shares of CON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concentra Group Holdings Parent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concentra Group Holdings Parent investors own include Skye Bioscience (SKYE), Skye Bioscience (SKYE), CervoMed (CRVO), Core Scientific (CORZ), ChargePoint (CHPT), Carnival Co. & (CCL) and Carrier Global (CARR).

Company Calendar

• Last Earnings: 3/03/2025
• Today: 3/12/2025
• Ex-Dividend for 4/1 Dividend: 3/18/2025
• Dividend Payable: 4/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Specialty outpatient clinics, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CON
• Previous Symbol: NYSE:CON
• CIK: 2014596
• Web: N/A
• Phone: (717) 972-1100
• Fax: N/A
• Employees: 11,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $28.63
• High Stock Price Target: $32.00
• Low Stock Price Target: $25.00
• Potential Upside/Downside: +37.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 13.78
• Forward P/E Ratio: 14.16
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 5.20
• Current Ratio: 1.52
• Quick Ratio: 1.52

Sales & Book Value

• Annual Sales: $1.90 billion
• Price / Sales: 1.39
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 127,340,000
• Free Float: N/A
• Market Cap: $2.65 billion
• Optionable: N/A
• Beta: N/A